Skip to content

Ansa Biotechnologies Awarded NSF SBIR Phase II Grant

  • Published

Building from a successful Phase I, Ansa will continue to develop and scale its enzymatic method for DNA synthesis with support from the National Science Foundation. Ansa’s technology enables a new DNA manufacturing process that promises to provide synthetic DNA to researchers in record time, accelerating biotechnology broadly.